C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/11 (2006.01) A61K 31/70 (2006.01) A61K 39/21 (2006.01) A61K 45/00 (2006.01) A61K 48/00 (2006.01) C07H 21/02 (2006.01) C07H 21/04 (2006.01) C12N 5/10 (2006.01) C12N 7/00 (2006.01) C12N 7/04 (2006.01) C12N 9/00 (2006.01) C12N 15/09 (2006.01) C12N 15/48 (2006.01) C12N 15/86 (2006.01)
Patent
CA 2168566
An enzymatic nucleic acid molecule which cleaves an immunodeficiency virus RNA in a gene required for viral replication, e.g., the nef or tat gene regions.
Molécule d'acide nucléique enzymatique effectuant le clivage d'un ARN du virus de l'immunodéficience dans un gène nécessaire à la réplication virale, par exemple les régions du gène nef ou tat.
Chowrira Bharat
Draper Kenneth G.
Mcswiggen James
Stinchcomb Daniel T.
Thompson James D.
Ribozyme Pharmaceuticals Inc.
Smart & Biggar
LandOfFree
Method and reagent for inhibiting human immunodeficiency... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and reagent for inhibiting human immunodeficiency..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and reagent for inhibiting human immunodeficiency... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2028209